Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Beni-Suef University
University of Kansas Medical Center
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Assiut University
First Affiliated Hospital of Fujian Medical University
Umeå University
Assiut University
Oslo University Hospital
Institut Mutualiste Montsouris
NRG Oncology
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Aarhus University Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pisa
Brown University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sohag University
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Mayo Clinic
CHU de Quebec-Universite Laval
Poitiers University Hospital
Tianjin Medical University Second Hospital
BLAD-HYA Group
Imperial College London
Rutgers, The State University of New Jersey
University of Washington
UNC Lineberger Comprehensive Cancer Center
University of Kansas Medical Center
Northwell Health
University Hospital, Toulouse
Institut Paoli-Calmettes
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cairo University
Cairo University
University of Gaziantep
Tianjin Medical University Second Hospital
University of Iowa
Mayo Clinic
Institut Cancerologie de l'Ouest
Centre Oscar Lambret